In addition, the regulatory network of the above two core genes was visualized, a TF-mRNA-miRNA network was constructed, and potential candidate compounds targeting EXT1 and FRZB were predicted to improve the symptoms of DCM patients (Addtional file 1: Figure S2). Here, TF is linked to familial dilated cardiomyopathy.